TD ASSET MANAGEMENT INC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 39 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$864,000
+17.6%
782,0000.0%0.00%0.0%
Q4 2018$735,000
-27.9%
782,0000.0%0.00%
-50.0%
Q3 2018$1,019,000
-2.1%
782,0000.0%0.00%0.0%
Q2 2018$1,041,000
+12.7%
782,0000.0%0.00%
+100.0%
Q1 2018$924,000
+1.7%
782,0000.0%0.00%0.0%
Q4 2017$909,000
-2.6%
782,0000.0%0.00%0.0%
Q3 2017$933,000
-11.1%
782,0000.0%0.00%
-50.0%
Q2 2017$1,050,000
+7.6%
782,0000.0%0.00%0.0%
Q1 2017$976,000
+8.6%
782,0000.0%0.00%0.0%
Q4 2016$899,000
-4.0%
782,0000.0%0.00%0.0%
Q3 2016$936,000
+16.3%
782,0000.0%0.00%
+100.0%
Q2 2016$805,000782,0000.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Mohican Financial Management, LLC 2,000,000$2,431,0004.67%
LINDEN ADVISORS LP 83,156,000$99,022,0003.51%
SSI INVESTMENT MANAGEMENT LLC 7,831,000$9,301,0000.79%
TENOR CAPITAL MANAGEMENT Co., L.P. 7,500,000$8,975,0000.70%
CAPSTONE INVESTMENT ADVISORS, LLC 15,000,000$17,896,0000.63%
CSS LLC/IL 8,280,000$9,866,0000.48%
Castle Creek Arbitrage, LLC 4,000,000$4,762,0000.48%
WOLVERINE ASSET MANAGEMENT LLC 35,968,000$42,764,0000.47%
DAFNA Capital Management LLC 573,000$682,0000.42%
Polar Asset Management Partners Inc. 15,000,000$17,857,0000.36%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders